Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its acquisition of Sugarmate, a popular mobile app for people with diabetes who use insulin. Sugarmate will become a wholly owned subsidiary of Tandem Diabetes Care, and will continue to be led by its founder, Josh Juster who has joined the Company as Vice President, Sugarmate. Financial terms of the acquisition were not disclosed.
The Sugarmate™ app (www.sugarmate.io) is designed to help people with diabetes visualize diabetes therapy data in innovative ways. It allows users to log glucose data and health and nutrition information, and can provide notifications and alerts to users, their family, and their caregivers.
“Our acquisition of Sugarmate represents an exciting addition to our digital offerings, and supports Tandem’s strategic vision to expand our ecosystem of diabetes-related products and services,” said John Sheridan, Tandem Diabetes Care president and chief executive officer. “We look forward to further advancing our mobile health offerings and continuing to develop and introduce new app features that benefit the broader community of people with diabetes, including the nearly 30,000 current Sugarmate users on pumps and multiple daily injections.”
“Sugarmate was founded as a way to help others in the diabetes community get the most out of their data and is the result of a passion for diabetes technology and consumer software development,” said Josh Juster, founder of Sugarmate. “Joining Tandem, a company that shares these passions, is a natural next step for Sugarmate, and will help us continue to build new features and functions for our current and future users.”
Information for Current Sugarmate App Users
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Sugarmate will continue to serve its current customers and operate as a standalone entity in the near term. Sugarmate app users, and anyone wanting to use the app, will continue to go through the Sugarmate app and website for information and support. Tandem is committed to continuing to support the Sugarmate app user community with innovative data tools, regardless of their choice of therapy.
Information for Current Tandem Customers
The Sugarmate app is not intended to replace the t:connect® mobile app, which is expected to launch for t:slim X2™ pump users this summer. The t:connect mobile app is being developed as a discreet secondary display for t:slim X2 pump users to view pump data on their mobile device and wirelessly upload therapy data to the cloud-based t:connect web application.